References
- Adams S. S., Crampton E. L., Nicholson J. S., Risdall P. C. (1974) Metabolism of flurbiprofen in man. Abstracts of papers on Ibuprofen and Flurbiprofen. XIII International Congress of Rheumatology, KyotoJapan, 1973. Current Medical Research and Opinion, London, 1731. Adams S. S., Crampton E. L., Nicholson J. S., Risdall P. C. (1974) Metabolism of flurbiprofen in man. Abstracts of papers on Ibuprofen and Flurbiprofen. XIII International Congress of Rheumatology, KyotoJapan, 1973. Current Medical Research and Opinion, London, 173
- Backmann F., Duckert F., Koller F. The Stuart-Prower Factor assay and its clinical significance. Thromb. Diath. Haemorrh. 1958; 2: 24–382. Backmann F., Duckert F., Koller F. The Stuart-Prower Factor assay and its clinical significance. Thromb. Diath. Haemorrh. 1958; 2: 24–38
- Bick R. L., Adams T., Schmalhorst W. R. Bleeding times, platelet adhesion and aspirin. Am. J. Clin. Pathol. 1975; 65: 69–723. Bick R. L., Adams T., Schmalhorst W. R. Bleeding times, platelet adhesion and aspirin. Am. J. Clin. Pathol. 1975; 65: 69–72
- Cartwright G. E. Diagnostic Laboratory Hematology, 4th Ed. Grune and Stratton, New York 19684. Cartwright G. E. Diagnostic Laboratory Hematology, 4th Ed. Grune and Stratton, New York 1968
- Koch-Weser J., Sellers E. M. Drug interactions with coumarin anticoagulants. N. Engl. J. Med. 1971; 285: 487–498; 547–5585. Koch-Weser J., Sellers E. M. Drug interactions with coumarin anticoagulants. N. Engl. J. Med. 1971; 285: 487–498; 547–558
- Koller F., Loeliger A., Duckert F. Experiments on a new clotting factor (Factor VII). Acta Haematol. (Basel) 1951; 6: 1–186. Koller F., Loeliger A., Duckert F. Experiments on a new clotting factor (Factor VII). Acta Haematol. (Basel) 1951; 6: 1–18
- Mielke C. H., Kaneshiro M. M., Maher I. A., Weiner J. M., Rapaport S. J. The standardized normal Ivy bleeding time and its prolongation by aspirin. Blood 1969; 34: 204–2157. Mielke C. H., Kaneshiro M. M., Maher I. A., Weiner J. M., Rapaport S. J. The standardized normal Ivy bleeding time and its prolongation by aspirin. Blood 1969; 34: 204–215
- Nyman D. The preparation of an artificial reagent for the one-stage Factor VIII assay. Thromb. Diath. Haemorrh. 1970; 23: 306–3128. Nyman D. The preparation of an artificial reagent for the one-stage Factor VIII assay. Thromb. Diath. Haemorrh. 1970; 23: 306–312
- Packham M. A., Warrior E. S., Glynn M. F., Senyi A. S., Mustard J. F. Alteration of the response of platelets to surface stimuli by pyrazole compounds. J. Exp. Med. 1976; 126: 183–1889. Packham M. A., Warrior E. S., Glynn M. F., Senyi A. S., Mustard J. F. Alteration of the response of platelets to surface stimuli by pyrazole compounds. J. Exp. Med. 1976; 126: 183–188
- Rüst O., Biland L., Thilo D., Nyman D., Duckert F. Prüfung des Antirheumatikums Tolmetin auf Interaktionen mit oralen Antikoagulatien. Schweiz. Med. Wochenschr. 1975; 105: 752–75310. Rüst O., Biland L., Thilo D., Nyman D., Duckert F. Prüfung des Antirheumatikums Tolmetin auf Interaktionen mit oralen Antikoagulatien. Schweiz. Med. Wochenschr. 1975; 105: 752–753
- Seiler R., Duckert F. Properties of 3-(1-phenyl-propyl)-4-oxycoumarin (Mar-coumar) in the plasma when tested in normal cases and under the influence of drugs. Thromb. Diath. Haemorrh. 1968; 19: 389–39611. Seiler R., Duckert F. Properties of 3-(1-phenyl-propyl)-4-oxycoumarin (Mar-coumar) in the plasma when tested in normal cases and under the influence of drugs. Thromb. Diath. Haemorrh. 1968; 19: 389–396
- Sigg A., Pestalozzi H., Clauss A., Koller F. Verstärkung der Antikoagulantienwirkung durch Butazolidin. Schweiz. Med. Wochenschr. 1956; 86: 1194–119512. Sigg A., Pestalozzi H., Clauss A., Koller F. Verstärkung der Antikoagulantienwirkung durch Butazolidin. Schweiz. Med. Wochenschr. 1956; 86: 1194–1195
- Thilo D., Nyman D. A study of the effects of the antirheumatic drug ibuprofen (Brufen) on patients being treated with the oral anticoagulant phenprocoumon (Marcoumar). J. Int. Med. Res. 1974; 2: 276–27813. Thilo D., Nyman D. A study of the effects of the antirheumatic drug ibuprofen (Brufen) on patients being treated with the oral anticoagulant phenprocoumon (Marcoumar). J. Int. Med. Res. 1974; 2: 276–278